CCR4 and neoplasm: Especially CCR4 expression in the tumor is correlated with failure of immunotherapies [18] and a target for therapeutic intervention, e.g., by agonists, antibody therapy or chimeric antigen receptors (CAR-) T cell immunotherapy [19,20,21,22,23].